echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > 100 medical representatives were interviewed.

    100 medical representatives were interviewed.

    • Last Update: 2020-10-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    September 22, Chengdu Commission issued a "case warning, case to promote reform, the health and health industry in the field of outstanding issues to promote the special rectification to the depth", the content of the content pointed out that the industry will step up efforts to clean up the discipline, never soft.
    120 people attended the meeting, including the main leaders of various medical and health institutions at all levels and the leaders in charge of medicines, equipment procurement and special rectification work.
    same period, according to the official website of Chengdu Fifth People's Hospital, the hospital held a supplier work interview in the academic hall, in the hospital material materials, equipment protection suppliers and agent bidding agency representatives a total of more than 100 people attended the meeting.
    The General Assembly focused on regulating procurement activities, correcting the business environment, combined with the post-epidemic era on the further standardization of hospital procurement activities related policy requirements, suppliers should cooperate with hospitals for procurement and supply of all aspects of self-examination and rectification issues, regulate procurement behavior.
    , according to Saibai Blue equipment observation, Chengdu Fifth People's Hospital official website in an obvious location hung out "health and health special rectification hotline and mailbox."
    it is understood that the hospital was founded in 1938, is the country's third-level A general hospital, Chengdu University of Traditional Chinese Medicine affiliated with the Fifth People's Hospital / Second Clinical Medical College.
    medical services radiate to more than 10 counties and cities in the western region of Chengdu, covering more than 5 million people.
    2019, 1.53 million doors and emergency departments, more than 85,000 hospitalizations and 58,000 operations.
    medical representatives were taken away for investigation on September 2, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published an article on "Taking the case as a guide to Chengdu's serious treatment of corruption in the medical field".
    refers directly to the hospital's original equipment and materials supply section director to take advantage of the convenience of his position, take a non-compliance approach for the relevant personnel in the supply of drugs, equipment procurement and other aspects of profit, accept bribes of more than 680,000 yuan.
    The Central Commission for Discipline Inspection pointed out that hospitals often work with the pharmaceutical representatives of enterprises to seek personal gain.
    Recently, a medical representative was arrested in a hospital, in addition to being arrested and investigated, was taken away because of his frequent access to the department, the medical representative is a regional manager, mobile phone has a lot of interest-related information, as well as customer transfer records.
    a cancer hospital in Guangzhou, a number of medical representatives were taken away by the hospital security department for investigation.
    , according to industry sources, a row of more than a dozen medical representatives were arrested.
    after the incident, the hospital issued a notice, clearly prohibited any representatives to the department during working hours.
    serious violators will be suspended from the corresponding company's products, the violation of the pharmaceutical representatives will be reported to the Department of Defense.
    industry for rebates, red envelopes and other governance has been carried out, and this for the treatment of pharmaceutical representatives has also increased efforts, recently a cancer hospital in Guangzhou issued a "medical representatives visit reception approval provisions" details.
    hospital pointed out that the pharmaceutical representative refers to drugs, medical equipment, reagents, medical supplies, third-party testing of the production, operation, sale of enterprises or agency staff.
    medical representatives to visit the reception approval process has very strict rules.
    First of all, employees submit the application form according to the requirements through the nail system, fill in the information about the proposed medical representative and his company, the time of the proposed reception, the place of reception to be received, the purpose of the proposed reception, etc.;
    examination and approval results are copied to the medical district chief, medical service and supervision room for the record.
    shall be submitted for approval in advance, and the number of medical representatives per reception shall not exceed five.
    employees and functional departments should review the identity of the medical representatives they receive to ensure that the information is true and require them to sign the Integrity Commitment.
    On September 16th, the State Health Insurance Administration issued the Guidance of the State Health Insurance Administration on the Establishment of a Credit Evaluation System for Pharmaceutical Prices and Recruitment, speaking, speaking that armed enterprises that have acts such as commercial bribery of pharmaceuticals will be included in the scope of medical prices and credit evaluation.
    From the date of issuance of the Guidance, pharmaceutical enterprises (including pharmaceutical production license holders, pharmaceutical and medical supplies production enterprises, distribution enterprises with a principal-agent relationship with production enterprises, and distribution enterprises, the same below) shall be included in the scope of pharmaceutical prices and credit evaluation in the course of pricing, bidding, performance, marketing, etc., through the misinreinment listed in the catalogue.
    The National Health Insurance Administration disclosed that between 2016 and 2019, more than half of the country's 100 compulsory drug companies were found to have given or indirectly given kickbacks, of which the most frequent enterprises involved in more than 20 cases in three years, a single case rebate amount of more than 20 million yuan.
    According to the Qianjiang Evening News, Zhejiang Province has launched the implementation of "brushing face into the hospital", not only to make health insurance payments through face recognition, to prevent "medical trouble", one of the important purposes is to monitor medical representatives.
    based on the experience of many hospitals, hospitals apply intelligent security systems, through the deployment of high-definition face recognition cameras, entrance control and alarm systems at various entrances and exits of hospitals.
    is also an important step in supporting the filing system of pharmaceutical representatives.
    The State Drug Administration in early June publicly solicited the opinions of the Measures for the Administration of the Filing of Pharmaceutical Representatives (Trial) (Draft for Comments) to regulate the practice of pharmaceutical representatives.
    Pharmaceutical representatives shall not carry out academic promotion and other activities without the consent of medical institutions, undertake the task of drug sales, collect funds and handle purchase and sale bills, shall not participate in the counting of the number of prescriptions for medicines issued by individual doctors, and directly provide donations and support to departments and individuals within medical institutions.
    can see that this is for enterprises, the national level has released the pursuit of rational drug use signals.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.